Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Braze stock sinking today followed a quarterly report that topped revenue expectations but left investors concerned a...
Get ahead of ARBE's Q1 2026 results with a practical framework. This guide breaks down what to watch in arbe (arbe) 2...
The company behind Claude just filed for an IPO, stirring questions about AI stocks and long-term growth. This guide ...
Headline-grabbing insider sales can feel alarming, but the true driver of stock performance is deal flow. Learn to se...
Tuesday brought a notable standout in the banking space as JPMorgan Chase topped market momentum. This piece breaks d...
Solana has faced headwinds, but solid metrics and developing catalysts could hint at a potential rally. This guide an...
As AI drives demand for faster memory and smarter processors, Micron and Intel stand out for different reasons. This ...
Greg Abel leads Berkshire Hathaway as the company holds a record cash pile. This in-depth guide explains what that me...
Institutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
ServiceNow stock edged past the market as an analyst upgrade lifted sentiment. This article breaks down what moved NO...
After the first quarter, the sharkninja 2026 earnings call reveals a company balancing strong demand with cost pressu...